Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile

scientific article

Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1593/NEO.08980
P932PMC publication ID2631141
P698PubMed publication ID19177201
P5875ResearchGate publication ID23957385

P50authorAnke van den BergQ37375568
Lu Ping TanQ39889837
P2093author name stringBart-Jan Kroesen
Johan H Gibcus
Peter Möller
Sibrand Poppema
Tjasso Blokzijl
Debora de Jong
Geert Harms
Rikst Nynke Schakel
P2860cites workReal-time quantification of microRNAs by stem-loop RT-PCRQ24535510
miR-15 and miR-16 induce apoptosis by targeting BCL2Q24536069
A microRNA expression signature of human solid tumors defines cancer gene targetsQ24541455
Accumulation of miR-155 and BIC RNA in human B cell lymphomasQ24556523
MicroRNA targeting specificity in mammals: determinants beyond seed pairingQ24607724
The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 bindingQ24644692
MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathwaysQ24650451
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study.Q46986151
Computational methods for microRNA target prediction.Q51907240
Teashirt 3 expression in the chick embryo reveals a remarkable association with tendon development.Q52019954
Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.Q53275615
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.Q53931762
Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.Q54780875
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemiaQ57234164
Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphomaQ57374943
The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18aQ64462273
Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implicationsQ69808243
A viral microRNA functions as an orthologue of cellular miR-155Q24652947
MicroRNA-155 is a negative regulator of activation-induced cytidine deaminaseQ24653222
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentQ24674155
Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomasQ24675877
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingQ27860529
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegansQ27861103
MicroRNA expression profiles classify human cancersQ28032481
Molecular evolution of a microRNA clusterQ28261071
Regulation of the germinal center response by microRNA-155Q29547777
miR-21-mediated tumor growthQ29616149
microRNA-155 regulates the generation of immunoglobulin class-switched plasma cellsQ29619307
MiR-150 controls B cell differentiation by targeting the transcription factor c-MybQ29619411
Genesis: cluster analysis of microarray dataQ29619630
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shockQ29619768
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasQ29622911
Global correlation of genome and transcriptome changes in classical Hodgkin lymphomaQ33260709
Hodgkin's disease: classification and differential diagnosisQ33539875
Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.Q34460936
MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblastsQ34521975
Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphomaQ34528341
miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expressionQ34762601
Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxiaQ35022890
miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurelyQ35758613
The role of microRNAs in normal hematopoiesis and hematopoietic malignanciesQ36600938
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomasQ36734930
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphomaQ40016162
MicroRNA expression profiling in classic Hodgkin lymphomaQ40033467
Downregulation of microRNAs-143 and -145 in B-cell malignanciesQ40076849
Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilonQ40247827
BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV.Q40274085
Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphomaQ40330082
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphomaQ40679662
Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient.Q41206007
Direct and sensitive miRNA profiling from low-input total RNA.Q41500041
Two neoplastic cell lines with unique features derived from Hodgkin's diseaseQ42801626
Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell linesQ45423789
Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomasQ45424270
Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cellsQ45877769
P433issue2
P921main subjectHodgkin lymphomaQ209369
microRNA expressionQ60681249
P304page(s)167-176
P577publication date2009-02-01
P1433published inNeoplasiaQ2962042
P1476titleHodgkin lymphoma cell lines are characterized by a specific miRNA expression profile
P478volume11

Reverse relations

cites work (P2860)
Q60045684A heterogeneous label propagation approach to explore the potential associations between miRNA and disease
Q38350728A high throughput experimental approach to identify miRNA targets in human cells.
Q27349177A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia
Q93059705Analyzing the regulation of miRNAs on protein-protein interaction network in Hodgkin lymphoma
Q38721982Argonaute 2 immunoprecipitation revealed large tumor suppressor kinase 1 as a novel proapoptotic target of miR-21 in T cells
Q36555745CD46 Activation Regulates miR-150-Mediated Control of GLUT1 Expression and Cytokine Secretion in Human CD4+ T Cells
Q39454046CD99 triggers upregulation of miR-9-modulated PRDM1/BLIMP1 in Hodgkin/Reed-Sternberg cells and induces redifferentiation
Q38570169Cancer hallmarks in induced pluripotent cells: new insights
Q36316601Cell-free Circulating miRNA Biomarkers in Cancer
Q35000982Cellular localization and processing of primary transcripts of exonic microRNAs.
Q37141244Cerebrospinal fluid miRNA profile in HIV-encephalitis.
Q38251994Challenges and opportunities of microRNAs in lymphomas.
Q38068839Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma
Q21245705Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases
Q35156115Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma
Q39660739Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer.
Q36594081Defining Plasma MicroRNAs Associated With Cognitive Impairment In HIV-Infected Patients
Q24628746Dinosaurs and ancient civilizations: reflections on the treatment of cancer
Q34300594Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits
Q39085506Dual role of miR-21 in CD4+ T-cells: activation-induced miR-21 supports survival of memory T-cells and regulates CCR7 expression in naive T-cells
Q88917792Efficient and accurate analysis of microRNA using a specific extension sequence
Q38920243Epigenetic regulation of microRNA expression in Hodgkin lymphoma.
Q37786570Expression of miRNAs in Lymphocytes: A Review
Q34664043Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation
Q42165154Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP.
Q34643277Hodgkin lymphoma
Q36684218Illumina microRNA profiles reveal the involvement of miR397a in Citrus adaptation to long-term boron toxicity via modulating secondary cell-wall biosynthesis
Q37393972Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice
Q38825359Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma
Q61807715Integrating random walk and binary regression to identify novel miRNA-disease association
Q55500631Involvement of MicroRNAs in the Aging-Related Decline of CD28 Expression by Human T Cells.
Q34646522Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation
Q39467028MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma
Q37045562MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1.
Q28472349MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism
Q34738140MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients
Q58753107MiRNA Dysregulation in Childhood Hematological Cancer
Q40867466Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables
Q42703031Micro-RNA Expression and Function in Lymphomas
Q39580400MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts.
Q37623563MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma
Q38860599MicroRNA-24 inhibits growth, induces apoptosis, and reverses radioresistance in laryngeal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein.
Q41223735MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis.
Q36602853MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies
Q36335261MicroRNAs as Biomarkers in Cancer
Q57814100MicroRNAs as Biomarkers of B-cell Lymphoma
Q26862811MicroRNAs in B cell development and malignancy
Q26824682MicroRNAs in B-cells: from normal differentiation to treatment of malignancies
Q33877654MicroRNAs of the immune system: roles in inflammation and cancer
Q93541677MicroRNAs: tiny players with a big role in the pathogenesis of leukemias and lymphomas
Q39336949Non-Coding RNAs in Hodgkin Lymphoma
Q41495243Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas.
Q47114178PRMDA: personalized recommendation-based MiRNA-disease association prediction
Q90387800Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors
Q37417538Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients.
Q21134925Rapid generation of microRNA sponges for microRNA inhibition
Q34557179Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies
Q42314673Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas
Q38222875Relevance of miR-21 in HIV and non-HIV-related lymphomas.
Q90308213Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21
Q38095676Role of microRNA in the pathogenesis of malignant lymphoma.
Q37868870Role of microRNAs in lymphoid biology and disease
Q33684046Sequencing bias: comparison of different protocols of microRNA library construction
Q26825764Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy
Q37478602The War on Cancer rages on.
Q39257795The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney.
Q35669733The interconnectedness of cancer cell signaling
Q35585502The relevance of miRNA-21 in HSV-induced inflammation in a mouse model
Q38129726The role of miR-150 in normal and malignant hematopoiesis
Q35885964Transcriptome dynamics of the microRNA inhibition response
Q38145508Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.
Q36583369WBSMDA: Within and Between Score for MiRNA-Disease Association prediction
Q38771877miR clusters target cellular functional complexes by defining their degree of regulatory freedom
Q98386299microRNA-21 regulates the proliferation of placental cells via FOXM1 in preeclampsia
Q37642868microRNAs in inflammation
Q50544689microRNAs: Key Players in Hematopoiesis.

Search more.